About this trial
The goal of this neuroimaging pilot study is to understand developmental differences in the impact of therapeutic wavelength light (blue light) versus a non-therapeutic wavelength (red light) on emotional brain function in depression. The main questions this study aims to answer are:
* Does acute exposure to blue light (vs red light) stabilize emotional brain function in depressed individuals? * Are stabilizing effects of blue light (vs red light) stronger for blue light in adolescents than young adults?
Participants will complete:
* A magnetic resonance imaging brain scan, in which we will examine the effect of blue versus red light on emotional brain function at rest and in response to rewards and losses. * A pupillometry test of sensitivity to blue vs red light * Clinical interviews and surveys * Screening measures for drug and alcohol use, MRI safety, and current pregnancy \[if relevant\] * Home sleep tracking with sleep diary and actigraphy for one week
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Elevated Depressive Symptoms [PHQ9≥5 And (Item 1≥1 or Item 2≥1)]
(If <18yr) Parent or guardian can attend the baseline clinical interview
Disqualifiers
Unable to read and write in English
Intellectual disability.
Left or mixed handedness
Changes to psychotropic medication type or dosage in the past 2 months
Trial design
Crossover
Treatments tested in this trial
Blue Light
Other interventionBlue light exposure
Red Light
Other interventionRed light exposure
Treatment groups
Trial outcomes
Primary outcomes
Amygdala cerebral blood flow during Blue vs Red light exposure
Cerebral blood flow will be assessed using pseudo-continuous arterial spin labeling collected during blue and red light exposures. Regional cerebral blood flow in the amygdala region of interest will be examined.
Ventral Striatum cerebral blood flow during Blue vs Red light exposure
Cerebral blood flow will be assessed using pseudo-continuous arterial spin labeling collected during blue and red light exposures. Regional cerebral blood flow in the ventral striatum region of interest will be examined.
Amygdala activity (loss>neutral) during Blue vs Red light exposure
This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Activation is defined by blood oxygen dependent signal within an amygdala region of interest on loss versus neutral (no win/no loss) trials.
Ventral Striatum activity (punish>neutral) during Blue vs Red light exposure
This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Activation is defined by blood oxygen dependent signal within a ventral striatum region of interest on win versus neutral (no win/no loss) trials.
Secondary outcomes
Medial prefrontal cortex cerebral blood flow during Blue vs Red light exposure
Cerebral blood flow will be assessed using pseudo-continuous arterial spin labeling collected during blue and red light exposures. Regional cerebral blood flow in the medial prefrontal region of interest will be examined.
Insula cerebral blood flow during Blue vs Red light exposure
Cerebral blood flow will be assessed using pseudo-continuous arterial spin labeling collected during blue and red light exposures. Regional cerebral blood flow in the insula regions of interest will be examined.
Ventromedial prefrontal cortex cerebral blood flow during Blue vs Red light exposure
Cerebral blood flow will be assessed using pseudo-continuous arterial spin labeling collected during blue and red light exposures. Regional cerebral blood flow in the ventromedial prefrontal cortex regions of interest will be examined.
Amygdala-whole brain functional connectivity (loss>neutral) during Blue vs Red light exposure
This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Functional connectivity is defined as a psychophysiological interaction between the seed region (amygdala) and the whole brain on loss versus neutral (no win/no loss) trials
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Pittsburgh
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator